Cross-sensitization to 5,7-dibromo-8-hydroxy quinoline (D.B.O.) [a compound of Synalar + D.B.O. cream].
D003877:Dermatitis, Contact / Q000209:etiology*; D004485:Eczema / Q000139:chemically induced* / Q000276:immunology; D005260:Female; D005446:Fluocinolone Acetonide / Q000009:adverse effects*; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects*; D008875:Middle Aged; D009824:Ointments; D015125:Oxyquinoline / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000276:immunology
D006912:Hydroxyquinolines; D009824:Ointments; D005446:Fluocinolone Acetonide; D015125:Oxyquinoline